Overview
The document provides detailed specifications and clinical evidence for the pRESET family of thrombectomy devices, manufactured by phenox GmbH. These devices are designed for mechanical thrombectomy procedures to treat ischemic stroke.

Specifications
The pRESET devices come in various models with different shaft diameters, working lengths, and shaft lengths. They are compatible with microcatheters of specific inner diameters and are suitable for vessels with minimum diameters ranging from 1.5 mm to 3 mm.

• Models include PRE-4-20, PRE-6-30, PRES-5-40, PRE-LUX-4-20, PRE-LT-3-20, and PRE-LT-4-20.
• Compatible with 0.021” and 0.0165”/0.017” microcatheters.

Clinical Evidence
The document cites studies demonstrating the efficacy of the pRESET devices in achieving high recanalization rates and favorable long-term neurological outcomes. Key findings include:

• High success rates in recanalization (TICI 2b/3) and favorable outcomes (mRS 0-2 at 90 days).
• Studies referenced include ARTESp, MR CLEAN, SWIFT-PRIME, EXTEND-IA, and ESCAPE.

Design Features
The pRESET devices incorporate unique design elements to enhance performance:

• Helical slit for maintaining cell shape integrity.
• Closed Ring Design for stable opening and wall apposition.
• Dual Type Cell Design for deep clot integration and flexibility.

Regulatory Status
The pRESET devices have received the CE Mark (CE 0297) but are not approved for sale or use in the United States.

Conclusion
The pRESET thrombectomy devices are backed by scientific research and clinical evidence, highlighting their effectiveness in clot retrieval and patient outcomes. The document emphasizes the devices' innovative design and compatibility with various microcatheters, making them a versatile choice for medical professionals.